Kaori Yamaki

Kashihara-shi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Correlation Between Lower Lobe Dose Parameters and Radiation Pneumonitis in Definitive Radiation Therapy for Non-Small Cell Lung Cancer.

Correlation Between Lower Lobe Dose Parameters and Radiation Pneumonitis in Definitive Radiation Therapy for Non-Small Cell Lung Cancer.

Journal: Thoracic cancer

Published: January 28, 2026

Evaluating Risk Factors Associating With Late Recurrence After Low-Dose-Rate Brachytherapy for Prostate Cancer Using Machine Learning.

Evaluating Risk Factors Associating With Late Recurrence After Low-Dose-Rate Brachytherapy for Prostate Cancer Using Machine Learning.

Journal: The Prostate

Published: January 07, 2026

Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.

Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.

Journal: The Prostate

Published: November 24, 2025

Prognostic Value of EGFR Mutation Subtypes After Linac-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis From EGFR-Mutated Non-Small Cell Lung Cancer.

Prognostic Value of EGFR Mutation Subtypes After Linac-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis From EGFR-Mutated Non-Small Cell Lung Cancer.

Journal: Brain tumor research and treatment

Published: November 15, 2025

Quality of life in patients who underwent low-dose-rate brachytherapy for prostate cancer with 10-year follow-up.

Quality of life in patients who underwent low-dose-rate brachytherapy for prostate cancer with 10-year follow-up.

Journal: Brachytherapy

Published: September 18, 2025

Efficacy and safety of definitive low-dose weekly cisplatin with concurrent radiotherapy for locally advanced head and neck squamous cell carcinoma.

Efficacy and safety of definitive low-dose weekly cisplatin with concurrent radiotherapy for locally advanced head and neck squamous cell carcinoma.

Journal: Auris, nasus, larynx

Published: March 08, 2025

Evaluating Local Doses for Prostate Cancer Treatment Using Low-Dose-Rate Brachytherapy Considering Oncological Control and Toxicity.

Evaluating Local Doses for Prostate Cancer Treatment Using Low-Dose-Rate Brachytherapy Considering Oncological Control and Toxicity.

Journal: The Prostate

Published: February 01, 2025

Impact of androgen deprivation therapy on sexual health in patients who underwent brachytherapy for prostate cancer.

Impact of androgen deprivation therapy on sexual health in patients who underwent brachytherapy for prostate cancer.

Journal: Andrology

Published: January 10, 2025

Testosterone Recovery and Quality of Life of Japanese Patients After Short-Term Neoadjuvant Androgen Deprivation Therapy With Low-Dose-Rate Brachytherapy for Prostate Cancer.

Testosterone Recovery and Quality of Life of Japanese Patients After Short-Term Neoadjuvant Androgen Deprivation Therapy With Low-Dose-Rate Brachytherapy for Prostate Cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 11, 2024

Long-term clinical outcomes after salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy.

Long-term clinical outcomes after salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy.

Journal: Japanese journal of clinical oncology

Published: October 10, 2024

Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer.

Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer.

Journal: Japanese journal of clinical oncology

Published: July 01, 2024

Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer.

Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer.

Journal: Journal of radiation research

Published: April 09, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026